Cefuroxime (2Nd Gen) Tablets/Capsules 250 mg, 500 mg Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets/Capsules
Available Strengths: 250 mg, 500 mg
Reference Brands: Ceftin, Zinacef(US & EU)
Category: Antibiotics
Cefuroxime inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, leading to bacterial lysis. It is effective against respiratory, urinary, skin, and soft tissue infections. Benefits include broad-spectrum activity, rapid bacterial eradication, and oral administration, making it a reliable choice for treating common bacterial infections when used appropriately.
Product Description:
Cefuroxime (2nd generation cephalosporin) tablets and capsules are approved in both the EU and US for treating respiratory, urinary, and skin bacterial infections. In the EU, brands like Ceftin and Zinacef are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic formulations are widely available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans. For regulatory support, compliance, and registration, visit PharmaTradz. We support seamless market access for cefuroxime, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.
Cefuroxime (2Nd Gen) Tablets/Capsules — third party manufacturing & bulk supply
Cefuroxime (2Nd Gen) Tablets/Capsules 250 mg, 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Cefuroxime (2Nd Gen) Tablets/Capsules is supplied as Oral Tablets/Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Cefuroxime (2Nd Gen) Tablets/Capsules listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Cefuroxime (2Nd Gen) Tablets/Capsules →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Rifaximin
Strength:
100 mg/5 mL, 200 mg, 550 mg
Form: Tablet / Oral Suspension
Reference Brands: Xifaxan (USA), Targaxan (EU), Normix (LATAM)
View Details
Ceftaroline
Strength:
600 mg
Form: Injection
Reference Brands: Teflaro (USA), Zinforo (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
